A Study of PHN-012 in Patients With Advanced Solid Tumors
Pheon Therapeutics
Pheon Therapeutics
St. Jude Children's Research Hospital
Turning Point Therapeutics, Inc.
Alterome Therapeutics, Inc.
Boston Scientific Corporation
Boston Scientific Corporation
SillaJen, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
NeoImmuneTech
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AstraZeneca
University of California, San Diego
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Boehringer Ingelheim
Pheon Therapeutics
Auricula Biosciences Inc.
DualityBio Inc.
Inhibrx Biosciences, Inc
Exelixis
Tanabe Pharma America, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
CRISPR Therapeutics
Yonsei University
Yonsei University
Seattle Children's Hospital
Seattle Children's Hospital
Centre Hospitalier Universitaire de Nīmes
Thomas Jefferson University
Sichuan Baili Pharmaceutical Co., Ltd.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Numab Therapeutics AG
German Cancer Research Center
Laval University
Laval University
HiberCell, Inc.
Stanford University
Sichuan University
Intensity Therapeutics, Inc.
LEO Pharma
LEO Pharma
University Health Network, Toronto
Sirtex Medical
Children's National Research Institute